SEC Form D · filed September 17, 2020
Finch Therapeutics Group, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Mark Smith · Somerville, MAExec · DirectorJames Burgess · Somerville, MAExecZain Kassam · Somerville, MAExecChristopher A. Cosmides · Somerville, MADirectorBenjamin Enerson · Somerville, MAExecJo A. Viney · Somerville, MADirectorDomenic Ferrante · Somerville, MADirectorJeffery A. Smisek · Somervlle, MADirectorChris Lange · Somerville, MADirectorAndrew Mulderry · Somerville, MADirectorAndrew Noh · Somerville, MAExecCarter G. Mcnabb · Louisville, CODirectorDavid T. Sinclair · Boston, MAExecKerry Song · San Clemente, CAExecLair G. Kennedy · Louisville, COExecGabriel Haddad Silva · Grand Cayman, Cayman IslandsDirectorShane Slominski · Minnetonka, MNDirectorSheryl Elsdon · Vancouver, British Columbia, CanadaDirectorAlexander T. Edwards · Boston, MAExecAllison Harr · Seattle, WADirectorBracken T. Darrell · Boston, MAExec · DirectorMichael Galgon · Seattle, WADirectorJackie N. Charlesworth · Hong Kong, Hong KongDirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorMilton Berlinski · New York, NYDirectorPeter Aberg · New York, NYDirectorTodd Haskins · New York, NYExecMarc N. Puglia · PROVIDENCE, RIExecPatrick Dunn · PROVIDENCE, RIExecHarry W. Lengsfield · NEW YORK, NYExecRuoyu Wang · San Francisco, CADirectorLei Xu · San Francisco, CADirectorRichard G. Schultze · Plano, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗